These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 36521000)

  • 1. Exposure to Thioguanine During 117 Pregnancies in Women With Inflammatory Bowel Disease.
    Crouwel F; Simsek M; de Boer MA; Mulder CJJ; van Andel EM; Creemers RH; van Asseldonk DP; van Bodegraven AA; Horjus CS; Visschedijk MC; Weusthuis ALM; Seinen ML; Jharap B; van Schaik FDM; Ahmad I; Boekema PJ; Tack GJ; Wormmeester L; Lutgens MWMD; van Boeckel PGA; Gilissen LPL; Kerkhof M; Russel MGVM; Hoentjen F; Bartelink ME; Kuijvenhoven JP; Maljaars JWJ; van Dop WA; Wonders J; van der Voorn MMPJA; Buiter HJC; de Boer NK
    J Crohns Colitis; 2023 May; 17(5):738-745. PubMed ID: 36521000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome of Pregnancies in Female Patients With Inflammatory Bowel Diseases Treated With Vedolizumab.
    Moens A; van Hoeve K; Humblet E; Rahier JF; Bossuyt P; Dewit S; Franchimont D; Macken E; Nijs J; Posen A; Strubbe B; Van Hootegem A; Van Moerkercke W; Vermeire S; Ferrante M;
    J Crohns Colitis; 2019 Jan; 13(1):12-18. PubMed ID: 30281093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety of Tioguanine During Pregnancy in Inflammatory Bowel Disease.
    van den Berg SA; de Boer M; van der Meulen-de Jong AE; Jansen JM; Hoentjen F; Russel MG; Mahmmod N; van Bodegraven AA; van der Woude CJ; Mulder CJ; de Boer NK
    J Crohns Colitis; 2016 Feb; 10(2):159-65. PubMed ID: 26503525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of Thiopurines During Conception and Pregnancy Is Not Associated With Adverse Pregnancy Outcomes or Health of Infants at One Year in a Prospective Study.
    Kanis SL; de Lima-Karagiannis A; de Boer NKH; van der Woude CJ
    Clin Gastroenterol Hepatol; 2017 Aug; 15(8):1232-1241.e1. PubMed ID: 28342949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pregnancy outcomes in inflammatory bowel disease patients treated with vedolizumab, anti-TNF or conventional therapy: results of the European CONCEIVE study.
    Moens A; van der Woude CJ; Julsgaard M; Humblet E; Sheridan J; Baumgart DC; Gilletta De Saint-Joseph C; Nancey S; Rahier JF; Bossuyt P; Cremer A; Dewit S; Eriksson C; Hoentjen F; Krause T; Louis E; Macken E; Milenkovic Z; Nijs J; Posen A; Van Hootegem A; Van Moerkercke W; Vermeire S; Bar-Gil Shitrit A; Ferrante M
    Aliment Pharmacol Ther; 2020 Jan; 51(1):129-138. PubMed ID: 31692017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicentre study and systematic review: Allopurinol exposure during pregnancy.
    Crouwel F; Simsek M; de Boer MA; van Asseldonk DP; Bhalla A; Weusthuis ALM; Gilissen LPL; Verburg RJ; Mares WGN; Jharap B; Kuijvenhoven JP; Oldenburg B; Buiter HJC; Julsgaard M; de Boer NK
    Aliment Pharmacol Ther; 2024 Aug; 60(4):503-518. PubMed ID: 38984819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pregnancy and newborn outcome of mothers with inflammatory bowel diseases exposed to anti-TNF-α therapy during pregnancy: three-center study.
    Bortlik M; Machkova N; Duricova D; Malickova K; Hrdlicka L; Lukas M; Kohout P; Shonova O; Lukas M
    Scand J Gastroenterol; 2013 Aug; 48(8):951-8. PubMed ID: 23834232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risks and pregnancy outcome after fetal reduction in dichorionic twin pregnancies: a Danish national retrospective cohort study.
    Kristensen SE; Ekelund CK; Sandager P; Jørgensen FS; Hoseth E; Sperling L; Balaganeshan SB; Hjortshøj TD; Gadsbøll K; Wright A; Wright D; McLennan A; Sundberg K; Petersen OB
    Am J Obstet Gynecol; 2023 May; 228(5):590.e1-590.e12. PubMed ID: 36441092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pregnancy outcome in patients with inflammatory bowel disease treated with thiopurines: cohort from the CESAME Study.
    Coelho J; Beaugerie L; Colombel JF; Hébuterne X; Lerebours E; Lémann M; Baumer P; Cosnes J; Bourreille A; Gendre JP; Seksik P; Blain A; Metman EH; Nisard A; Cadiot G; Veyrac M; Coffin B; Dray X; Carrat F; Marteau P;
    Gut; 2011 Feb; 60(2):198-203. PubMed ID: 21115547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrauterine exposure and pharmacology of conventional thiopurine therapy in pregnant patients with inflammatory bowel disease.
    Jharap B; de Boer NK; Stokkers P; Hommes DW; Oldenburg B; Dijkstra G; van der Woude CJ; de Jong DJ; Mulder CJ; van Elburg RM; van Bodegraven AA;
    Gut; 2014 Mar; 63(3):451-7. PubMed ID: 23424097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pregnancy outcomes in women with inflammatory bowel disease following exposure to thiopurines and antitumor necrosis factor drugs: a systematic review with meta-analysis.
    Mozaffari S; Abdolghaffari AH; Nikfar S; Abdollahi M
    Hum Exp Toxicol; 2015 May; 34(5):445-59. PubMed ID: 25378092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of surgical therapies for inflammatory bowel disease on female fertility.
    Lee S; Crowe M; Seow CH; Kotze PG; Kaplan GG; Metcalfe A; Ricciuto A; Benchimol EI; Kuenzig ME
    Cochrane Database Syst Rev; 2019 Jul; 7(7):CD012711. PubMed ID: 31334846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of Pregnancies for Women Undergoing Endoscopy While They Were Pregnant: A Nationwide Cohort Study.
    Ludvigsson JF; Lebwohl B; Ekbom A; Kiran RP; Green PH; Höijer J; Stephansson O
    Gastroenterology; 2017 Feb; 152(3):554-563.e9. PubMed ID: 27773807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maternal age and adverse pregnancy outcome: a cohort study.
    Khalil A; Syngelaki A; Maiz N; Zinevich Y; Nicolaides KH
    Ultrasound Obstet Gynecol; 2013 Dec; 42(6):634-43. PubMed ID: 23630102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 6-Thioguanine for Crohn's disease during pregnancy: thiopurine metabolite measurements in both mother and child.
    de Boer NK; Van Elburg RM; Wilhelm AJ; Remmink AJ; Van Vugt JM; Mulder CJ; Van Bodegraven AA
    Scand J Gastroenterol; 2005 Nov; 40(11):1374-7. PubMed ID: 16334449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of azathioprine and corticosteroids during pregnancy and birth outcome in women diagnosed with inflammatory bowel disease.
    Plauborg AV; Hansen AV; Garne E
    Birth Defects Res A Clin Mol Teratol; 2016 Jun; 106(6):494-9. PubMed ID: 27301563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Effects of Active IBD During Pregnancy in the Era of Novel IBD Therapies.
    de Lima-Karagiannis A; Zelinkova-Detkova Z; van der Woude CJ
    Am J Gastroenterol; 2016 Sep; 111(9):1305-12. PubMed ID: 27349339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complications of pregnancy and child development after cessation of treatment with 6-mercaptopurine for inflammatory bowel disease.
    Zlatanic J; Korelitz BI; Rajapakse R; Kim PS; Rubin SD; Baiocco PJ; Panagopoulos G
    J Clin Gastroenterol; 2003 Apr; 36(4):303-9. PubMed ID: 12642735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pregnancy outcomes in women with inflammatory bowel disease: a large community-based study from Northern California.
    Mahadevan U; Sandborn WJ; Li DK; Hakimian S; Kane S; Corley DA
    Gastroenterology; 2007 Oct; 133(4):1106-12. PubMed ID: 17764676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse birth outcomes and early-life infections after in utero exposure to corticosteroids for inflammatory bowel disease: a Danish nationwide cohort study.
    Jølving LR; Nielsen J; Andersen ML; Friedman S; Nørgård BM
    BMC Med; 2023 Apr; 21(1):140. PubMed ID: 37046314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.